Digoxin
Overview
Digoxin is a cardiac glycoside derived from the foxglove plant, Digitalis lanata. It is used to treat various heart conditions, particularly atrial fibrillation and heart failure.
API suppliers (5)
Suppliers of Digoxin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 3 of 5 suppliers.
2 of 5 hold a GMP certificate on record in the EU or UK registers
- C-SQUARED PHARMA LTDUnited States1 active DMF
- ALCHEM INTERNATIONAL PRIVATE LTD1 active DMF GMP on record
- BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGGermany
- ALCHEM INTERNATIONAL LTDUnited States GMP on record
- VITAL LABORATORIES PVT LTD
EU CEP holders (3)
Companies holding a valid EU Certificate of Suitability (CEP) for Digoxin, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.
Therapeutic areas
Do you supply Digoxin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.